市場調查報告書
商品編碼
1617114
寵物益生菌補充品市場預測至 2030 年:按形式、功能、銷售管道和地區進行的全球分析Pet Probiotics Supplements Market Forecasts to 2030 - Global Analysis By Form, Functionality, Sales Channel and By Geography |
根據 Stratistics MRC 的數據,2024 年全球寵物益生菌補充品市場規模將達到 7.8 億美元,預計在預測期內複合年成長率為 5.7%,到 2030 年將達到 10.88 億美元。
寵物益生菌食品是一種旨在支持寵物(尤其是狗和貓)消化器官系統健康的營養食品。這些補充品含有活的有益細菌和酵母菌株,有助於維持腸道菌叢的健康平衡。它通常在寵物從疾病中恢復、抗生素治療後或在可能破壞腸道環境的壓力時期使用。
根據世界衛生組織 (WHO) 的規定,活細菌數必須至少為 106 CFU/g 才能產生有益的健康影響。
寵物健康意識不斷增強
寵物飼主越來越意識到保持寵物整體健康的重要性,不僅包括身體健康,還包括腸道健康。益生菌含有有益細菌,可促進寵物消化器官系統的健康,改善營養吸收,減少腹瀉等胃腸道疾病,並增強免疫功能。隨著寵物飲食的發展和對均衡天然食品的關注,益生菌逐漸被認為是寵物日常保健的重要組成部分。由於透過社群媒體獲取資訊的機會增加、獸醫學的進步以及寵物健康影響者的存在,人們對寵物健康的認知不斷增強,飼主在預防健康問題方面變得更加積極主動。
昂貴的益生菌產品
優質益生菌產品的高價是寵物益生菌補充品市場成長的主要障礙。優質益生菌承諾卓越的品質和更有效的效果,因此通常售價更高,因為它們採用先進的技術、更高品質的成分和更嚴格的製造標準。這些成本轉嫁給了消費者,使得那些不願意為寵物投資昂貴的補充品的飼主更難獲得這些產品,特別是與其他寵物保健食品相比。
人們越來越關注天然和有機產品
寵物飼主擴大尋求全面、無化學物質的解決方案來改善寵物的健康,特別是腸道健康、免疫支持和消化。這種向天然產品的轉變正在推動由不含人工添加劑、防腐劑和有害化學物質的有機成分製成的益生菌的發展。這些補充品正在成為一種更安全、更有效的替代品,取代可能產生副作用的傳統寵物藥物。隨著人們對寵物腸道健康重要性的認知不斷提高,品牌開始專注於使用天然植物來源成分、有益細菌和有機營養素來配製益生菌產品。
缺乏法律規範
寵物益生菌補充品市場缺乏法律規範,對消費者和製造商都構成了重大挑戰。與人類益生菌受到 FDA 等機構嚴格監管不同,寵物益生菌的監管有限且產品品質和安全標準不一致。缺乏監督意味著某些補充品可能不含他們聲稱的成分,可能無效,甚至可能對您的寵物有害。如果沒有標準化的測試和明確的標籤指南,寵物飼主可能會難以選擇合適的產品,這可能會使寵物的健康面臨風險。
COVID-19 大流行對寵物益生菌補充品市場產生了重大影響。最初,供應鏈中斷和製造停工導致原料和最終產品短缺,影響了產品可用性。除此之外,還有物流方面的挑戰,導致出貨延遲和成本增加。疫情期間,銷售額有所成長,因為飼主優先考慮寵物的健康,而飼主寵物主人則面臨財務限制,並減少了補充品等非必需品的支出。儘管面臨這些挑戰,疫情加速了向網路購物的轉變,並幫助維持了市場成長。
膠囊細分市場預計將在預測期內成為最大的細分市場
透過提供一種方便、高效和準確的方式為寵物提供有益細菌,膠囊細分市場預計在預測期內將佔據最大佔有率。隨著寵物飼主越來越關注動物的消化器官系統健康,膠囊提供了一種易於服用的替代品,取代了難以準確或持續服用的粉末和液體。膠囊可確保劑量準確,保持益生菌的效力,並防止它們因暴露在空氣和濕氣中而劣化。此外,對腸道健康的寵物補充品的需求不斷成長,正在推動膠囊配方的創新,提供適合動物體型、品種和健康需求的選擇。
消化器官系統健康領域預計在預測期內複合年成長率最高
由於專注於增強寵物益生菌補充品以促進寵物的整體健康,消化器官系統健康領域預計將在預測期內快速成長。這些補充品旨在透過將有益細菌引入寵物的消化器官系統來改善腸道健康、增強免疫力並支持最佳消化。隨著越來越多的飼主意識到保持寵物消化器官系統平衡的重要性,對高品質益生菌的需求激增。這些補充品專為解決腹瀉、便秘、食物過敏和其他消化器官系統疾病等特定問題而量身定做。益生菌配方的進步現在包括物種特異性菌株,可確保對不同類型的寵物(包括狗、貓和異國風動物)發揮最大功效。這些因素正在推動該細分市場的成長。
預計亞太地區將在整個預測期內保持最大的市場佔有率。隨著中國、日本和印度等國家寵物擁有量的不斷增加,寵物飼主越來越意識到保持寵物健康,尤其是消化器官系統健康的重要性。獸醫越來越認知到寵物益生菌的好處,並建議使用它們來解決胃腸道健康、過敏和免疫系統支持等問題。人們對寵物腸道環境與其整體健康之間聯繫的認知不斷提高,進一步推動了這一趨勢。益生菌補充品的種類繁多,包括粉末、膠囊和零食,使飼主可以更輕鬆地將這些產品納入該全部區域寵物的飲食中。
據估計,歐洲地區在預測期內的複合年成長率最高。寵物飼主越來越認知到腸道健康對寵物的重要性,並認知到平衡的消化器官系統支持整體健康,增強免疫力並提高能量水平。因此,對幫助寵物維持健康消化功能的益生菌補充品的需求不斷增加,尤其是在歐洲,寵物擁有率很高,飼主願意投資優質健康食品。寵物胃腸道問題、過敏和敏感性的普遍存在進一步推動了對益生菌解決方案的需求。
According to Stratistics MRC, the Global Pet Probiotics Supplements Market is accounted for $780 million in 2024 and is expected to reach $1,088 million by 2030 growing at a CAGR of 5.7% during the forecast period. Pet probiotics supplements are dietary products designed to support the digestive health of pets, particularly dogs and cats. These supplements contain live beneficial bacteria or yeast strains that help maintain a healthy balance of gut flora. They are often used to help pets recover from illnesses, after antibiotic treatments, or during times of stress that might disrupt their gut health.
According to the World Health Organization (WHO), the minimum live bacterial count should be 106 CFU/g to have beneficial health effects.
Rising awareness of pet health
Pet owners are becoming more conscious of the importance of maintaining their pets' overall well-being, not just in terms of physical fitness but also gut health. Probiotics, which contain beneficial bacteria, help promote a healthy digestive system in pets, improving nutrient absorption, reducing gastrointestinal issues like diarrhea, and boosting immune function. As pets' diets evolve, with more focus on balanced, natural foods, probiotics are gaining recognition as an essential part of a pet's daily regimen. The rise in awareness of pet health has been fueled by greater access to information through social media, veterinary care advancements, and pet health influencers, making owners more proactive in preventing health issues.
High cost of premium probiotic products
The high cost of premium probiotic products is a significant barrier to the growth of the pet probiotics supplements market. Many premium probiotics, which promise superior quality and more effective results, are often priced higher due to the use of advanced technology, higher-quality ingredients, and stringent manufacturing standards. These costs are passed on to consumers, making them less accessible to pet owners who may be hesitant to invest in expensive supplements for their pets, especially when compared to other pet health products.
Rising focus on natural and organic products
Pet owners are increasingly seeking holistic and chemical-free solutions to improve their pets' health, particularly in gut health, immune support, and digestion. This shift toward natural products is driving the development of probiotics that are made from organic ingredients, free from artificial additives, preservatives, and harmful chemicals. These supplements are seen as safer and more effective alternatives to traditional pet medications, which may have side effects. With rising awareness about the importance of gut health for pets, brands are focusing on formulating probiotic products with natural, plant-based ingredients, beneficial bacteria and organic nutrients.
Lack of regulatory oversight
The lack of regulatory oversight in the pet probiotics supplement market is creating significant challenges for both consumers and manufacturers. Unlike human probiotics, which are subject to stringent regulations by agencies like the FDA, pet probiotics face limited scrutiny, leading to inconsistent product quality and safety standards. This lack of oversight means that some supplements may not contain the ingredients they claim, may be ineffective, or could even be harmful to pets. Without standardized testing or clear labeling guidelines, pet owners may struggle to choose the right products, potentially risking their pets' health.
The COVID-19 pandemic significantly impacted the pet probiotics supplements market. Initially, supply chain disruptions and manufacturing halts led to shortages of raw materials and finished products, affecting product availability. This was further compounded by logistical challenges, which delayed shipments and increased costs. While some pet owners prioritized their pets' health during the pandemic, driving an increase in sales, others faced financial constraints, which led to reduced discretionary spending on non-essential items like supplements. Despite the challenges, the pandemic accelerated the shift toward online shopping, which helped maintain market growth.
The Capsules segment is expected to be the largest during the forecast period
Capsules segment is expected to dominate the largest share over the estimated period, by offering a convenient, efficient, and precise way to deliver beneficial bacteria to pets. As pet owners become more conscious of their animals' digestive health, capsules provide an easy-to-administer alternative to powders or liquids, which may be difficult to dose correctly or administer consistently. Capsules ensure accurate dosage and maintain the potency of probiotics, preventing degradation from exposure to air or moisture. Additionally, the rising demand for specialized pet supplements focused on gut health is driving innovation in capsule formulations, with options tailored for different animal sizes, breeds, and health needs.
The Digestive Health segment is expected to have the highest CAGR during the forecast period
Digestive Health segment is estimated to grow at a rapid pace during the forecast period as it focuses on enhancing pet probiotic supplements to promote overall wellness in pets. These supplements are designed to improve gut health, boost immunity, and support optimal digestion by introducing beneficial bacteria into a pet's digestive system. As more pet owners recognize the importance of maintaining their pets' digestive balance, the demand for high-quality probiotics has surged. These supplements are tailored to address specific issues like diarrhea, constipation, food sensitivities, and other digestive disturbances. Advances in probiotic formulations now include species-specific strains, ensuring maximum effectiveness for different types of pets, whether dogs, cats or exotic animals. These elements are boosting the segmental growth.
Asia Pacific region is poised to hold the largest share of the market throughout the extrapolated period. As pet ownership continues to rise in countries like China, Japan, and India, pet owners are becoming more aware of the importance of maintaining their pets' health, particularly through digestive wellness. Veterinarians, recognizing the benefits of probiotics for pets, are increasingly advising their use to address issues like gastrointestinal health, allergies, and immune system support. This growing trend is further fueled by the rise in awareness of pet gut health and its link to overall well-being. The availability of a wide range of probiotic supplements, including powders, capsules, and treats, has made it easier for pet owners to integrate these products into their pets' diets across the region.
Europe region is estimated to witness the highest CAGR during the projected time frame. Pet owners are increasingly aware of the importance of gut health for their pets, recognizing that a balanced digestive system supports overall well-being, boosts immunity, and improves energy levels. As a result, there is growing demand for probiotic supplements that aid in the maintenance of healthy digestion in pets, especially in Europe where pet ownership is high and owners are willing to invest in premium health products. The growing prevalence of gastrointestinal issues, allergies, and sensitivities among pets further fuels the demand for probiotic solutions.
Key players in the market
Some of the key players in Pet Probiotics Supplements market include BASF SE, Bayer AG, Cargill, Incorporated, Kemin Industries, Lallemand Inc, Mars Petcare Inc, Nestle Purina Petcare, Nutramax Laboratories, VetriScience Laboratories, Probiotics International Ltd, Wellness Pet Company, Hill's Pet Nutrition, Troy Animal Healthcare, Alltech and Pala-Tech Laboratories.
In November 2024, Dhanuka Agritech Limited, one of India's leading agri input companies, has signed an agreement to acquire international rights to the active ingredients Iprovalicarb and Triadimenol. With this acquisition, Dhanuka plans to expand its footprint in more than 20 countries, including the regions of LATAM, EMEA and Asia including India.
In April 2024, General Mills acquired the Belgium-based premium pet food brand Edgards and Cooper as part of its Accelerate Strategy. With this acquisition, General Mills aims to target the premium pet market in European markets.